Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Todd Harrison Discusses Biopharmaceutical Investments

Todd Harrison Discusses Biopharmaceutical Investments

FromMasters in Business


Todd Harrison Discusses Biopharmaceutical Investments

FromMasters in Business

ratings:
Length:
78 minutes
Released:
Jun 28, 2018
Format:
Podcast episode

Description

Bloomberg Opinion columnist Barry Ritholtz interviews Todd Harrison, a founding partner and chief investment officer at the hedge fund CB1 Capital, which focuses on cannabinoid-based solutions and biopharmaceutical applications and therapies. Prior to his work with CB1 Capital, Harrison spent almost three decades on Wall Street managing risk and researching financial market strategies. He was also the
founder and CEO of Minyanville Media Inc., an Emmy-winning financial media company covering global markets in real time. 
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
Released:
Jun 28, 2018
Format:
Podcast episode

Titles in the series (100)

Bloomberg Opinion columnist Barry Ritholtz looks at the people and ideas that shape markets, investing and business.